A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Phase 1
Completed
- Conditions
- Peritoneal Carcinomatosis
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Genelux GmbH
- Target Recruit Count
- 9
- Registration Number
- NCT01443260
- Locations
- 🇩🇪
University Hospital Tuebingen, Tuebingen, Germany
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Advanced Cancers (Solid Tumors)
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Genelux GmbH
- Target Recruit Count
- 43
- Registration Number
- NCT00794131
- Locations
- 🇬🇧
Royal Marsden Hospital, Surrey, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath